Pharmaceutical Manufacturing: USAID encourages Armenia to hold legislative reforms

The government of Armenia has developed a special project aimed at spurring domestic pharmaceutical manufacturing following the recommendation of international organizations.

There are 4,116 trade names of medications registered in the Armenian market, 7.3 percent of which is produced locally. This number is too low from the point of view of national safety (in case if export stopped, local production would not suffice); the share of domestically produced medication should make at least 20 percent. Lala Margaryants, Pharmaceutical Cluster Coordinator at USAID-funded CAPS (Competitive Armenian Private Sector) addressed this issue during the Armenian Pharmaceutical Competitiveness Third International conference held earlier this month.

In his speech at the conference USAID/Armenia Deputy Mission Director John Seong linked that issue with the lack of proper legislative field, stressing the importance of eliminating the current obstacles related to the shortcomings in legislation, branding, marketing and promotion, insufficiency of investments, indifference of beneficiaries.

RA Minister of Economy Nerses Yeritsyan encouraged local producers to explore new markets – win the local market and access international ones – stressing the Government’s readiness to support active companies that will propose new investment programs and innovative solutions.

This conference was one of the key factors that preconditioned the approval of the draft law (during the RA government session) establishing rules of proper pharmaceutical manufacturing.

According to the draft, manufacturing license is granted by internationally certified companies only.

This 75-page draft, developed by the RA Ministry of Healthcare, covers all the issues related to manufacturing of drugs, quality assurance, the rules of return of drugs in case of customer complaints related to defective goods.

Those granted pharmaceutical manufacturing license are obliged to adjust their activities to this draft law by January 1, 2012.